FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1670-1671 October 18, 2007 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

By Elizabeth Siegel Watkins. 351 pp. Baltimore, Johns Hopkins University Press, 2007. $45. ISBN 978-0-8018-8602-7.

Much has been written about postmenopausal estrogen therapy. No other prescription medication has had such successful promotion to patients and physicians, such widely debated opinions about its use, or such striking ups and downs in the number of prescriptions filled. The use of noncontraceptive estrogen was originally advocated for the treatment of troublesome symptoms of menopause. No one argues against this indication, but the short-term use for menopausal symptoms does not explain why one estrogen product became the best-selling prescription medication in the United States. This wonderful book tells the story.

In The Estrogen Elixir, Elizabeth Siegel Watkins describes the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.